SM
Sabby Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Hold |
0
| – | – | – | 115 |
|
2017
Q2 | – | Sell |
-28,626
| Closed | -$410K | – | 147 |
|
2017
Q1 | $410K | Sell |
28,626
-41,414
| -59% | -$593K | 0.02% | 89 |
|
2016
Q4 | $969K | Buy |
+70,040
| New | +$969K | 0.06% | 56 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 182 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 180 |
|
2016
Q1 | – | Sell |
-67,710
| Closed | -$901K | – | 193 |
|
2015
Q4 | $901K | Sell |
67,710
-193,885
| -74% | -$2.58M | 0.05% | 88 |
|
2015
Q3 | $2.81M | Sell |
261,595
-57,180
| -18% | -$614K | 0.12% | 49 |
|
2015
Q2 | $2.57M | Sell |
318,775
-5,053,025
| -94% | -$40.7M | 0.09% | 48 |
|
2015
Q1 | $5.07M | Buy |
5,371,800
+5,169,100
| +2,550% | +$4.88M | 0.21% | 18 |
|
2014
Q4 | $184 | Buy |
+202,700
| New | +$184 | 0.01% | 94 |
|
2014
Q1 | – | Sell |
-1,000,000
| Closed | -$1.8M | – | 117 |
|
2013
Q4 | $1.8M | Buy |
+1,000,000
| New | +$1.8M | 0.11% | 27 |
|